TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 3 | -1 | -4 | -3 | 1 | -19 | 6 | -4 |
| P | %wins | 67 | 33 | 33 | 67 | 33 | 50 | 47 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/20/22 16:05 | 4/19/22 | INZY | Inozyme Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bolte Axel | MA | DO | CEO | P | 250 | 3.69 | 0 | 68 | 36 | 259 | D | ||||||||||||||
6/7/16 17:06 | 6/3/16 | OPHT | Ophthotech Corp. | DE | Health | Drug | Pharmaceutical Preparations | Bolte Axel | NY | D | P | 199 | 56.97 | 24 | 4 | 140 | 6 | D | 30 | 18 | -5 | 23 | 15 | 26 | 15 | 10 | 1 | -6 | -6 | -10 | -39 | ||
4/1/15 17:54 | 3/30/15 | OPHT | Ophthotech Corp. | DE | Health | Drug | Pharmaceutical Preparations | Bolte Axel | NY | D | P | 24 | 48.27 | 16 | 1 | 25 | 3 | D | 30 | 20 | 6 | -15 | -12 | -9 | -1 | 1 | 3 | -3 | 12 | -22 | -9 | ||
10/7/13 20:53 | 9/25/13 | OPHT | Ophthotech Corp. | DE | Health | Drug | Pharmaceutical Preparations | Bolte Axel | NY | D | P | 44 | 22.00 | 33 | 2 | New | 2 | D | 32 | 16 | -6 | -10 | 1 | 0 | 3 | 21 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |